Herceptin Research - Side-effects, Breast Cancer, Treatment, Therapy

Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.


Herceptin Research Today

Home

View Latest Issue

Information About Herceptin

Books on Herceptin

Advertising in Research Today

View Other Research Today Publications



Volume 3 (2006), Issue 9 (September)

  1. Investigating the Combination of Trastuzumab and HER2/neu Peptide Vaccines for the Treatment of Breast Cancer.
    Ann Surg Oncol, 13(8): 1085-98. [Abstract] [Full-text]
  2. Chromogenic in situ hybridization to detect HER-2/neu gene amplification in histological and ThinPrep-processed breast cancer fine-needle aspirates: a sensitive and practical method in the trastuzumab era.
    Oncologist, 11(8): 878-86. [Abstract] [Full-text]
  3. Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer.
    Oncologist, 11(8): 857-67. [Abstract] [Full-text]
  4. HER2-positive Breast Cancer Brain Metastases: Multiple Responses to Systemic Chemotherapy and Trastuzumab-a Case Report.
    J Neurooncol, 79(3): 289-92. [Abstract] [Full-text]
  5. Enhancement of radiosensitivity by dual inhibition of the HER family with ZD1839 ("Iressa") and trastuzumab ("Herceptin").
    Int J Radiat Oncol Biol Phys, 66(2): 528-36. [Abstract] [Full-text]
  6. Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells.
    Cancer Gene Ther, 13(10): 958-68. [Abstract] [Full-text]
  7. Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells.
    Mol Cancer Ther, 5(9): 2172-81. [Abstract] [Full-text]
  8. Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors.
    Bioconjug Chem, 17(5): 1190-9. [Abstract] [Full-text]
  9. Controversies in the Assessment of HER-2: More Questions Than Answers.
    Adv Anat Pathol, 13(5): 263-269. [Abstract] [Full-text]
  10. Surface plasmon resonance investigations of human epidermal growth factor receptor 2.
    Appl Spectrosc, 60(9): 994-1003. [Abstract] [Full-text]
  11. Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
    BMC Cancer, 6: 225. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Herceptin Research Today. All Rights Reserved.



Herceptin Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)



Herceptin Books

I Am Not My Breast Cancer: Women Talk Openly About Love and Sex, Hair Loss and Weight Gain, Mothers and Daughters, and Being a Woman with Breast Cancer

I Am Not My Breast Cancer: Women Talk Openly About Love and Sex, Hair Loss and Weight Gain, Mothers and Daughters, and Being a Woman with Breast Cancer